Impact of APOC3 Gene Variants on Liver Health in Obese Individuals
Author Information
Author(s): Sentinelli Federica, Romeo Stefano, Maglio Cristina, Incani Michela, Burza Maria A, Scano Francesca, Coccia Federica, Cossu Efisio, Leonetti Frida, Baroni Marco G
Primary Institution: University of Cagliari, Italy
Hypothesis
Do APOC3 variants rs2854116 and rs2854117 affect liver damage, lipid levels, and insulin resistance in obese individuals?
Conclusion
The study found no significant association between APOC3 polymorphisms and liver health indicators in obese subjects.
Supporting Evidence
- No significant differences were found in liver enzyme levels between carriers of the APOC3 variants and wild-type homozygotes.
- Insulin resistance indices were similar across genotype classes.
- Previous studies suggested a link between APOC3 variants and liver health, but this study did not confirm that association.
Takeaway
The study looked at whether certain gene changes affect liver health in obese people, but found no link.
Methodology
585 obese Italians were genotyped for APOC3 variants and underwent glucose tolerance tests and liver enzyme measurements.
Limitations
The study lacked direct measurement of hepatic fat content in all subjects.
Participant Demographics
All participants were unrelated obese Caucasians with a median BMI of 41 kg/m2.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website